Donohue, Michael C <br/><br/>
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.  [electronic resource] 

 -  JAMA neurology  Aug 2014 
 - 961-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2014.803  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--diagnosis<br/>Amyloid beta-Peptides--metabolism<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Apolipoprotein E4--genetics<br/>Clinical Trials as Topic--standards<br/>Cognition Disorders--diagnosis<br/>Disease Progression<br/>Early Diagnosis<br/>Executive Function--physiology<br/>Feasibility Studies<br/>Female<br/>Heterozygote<br/>Humans<br/>Male<br/>Memory, Episodic<br/>Middle Aged<br/>Neuropsychological Tests--standards<br/>Positron-Emission Tomography<br/>Prodromal Symptoms<br/>Prospective Studies